Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis
Clinical trial NCT07044115 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07044115
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-26
- Primary completion
- 2025-01-16
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.